News Sentiment

GILD34 sentiment intelligence

Gilead Sciences, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 48 Balanced news tone 14 relevant articles
Exchange SAO Brazil
Sector Healthcare Market context
Industry Drug Manufacturers - General Read-through group
Latest close 332.38 Week of 10 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

91/100 classification confidence.

Company focus 14

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

-3.0% over one week, +4.9% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Gilead Sciences chief comm & corp aff officer sells $389,757 in stock By Investing.com

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 91/100 classification
One-week reaction -3.0% Price reacting lower
Trend fit Trend inactive 4.9% over four weeks
Fair value 27.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 8
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 14
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
GuruFocus 6
Reuters 2
Investing.com South Africa 1
Barchart.com 1
Proactive financial news 1
PR Newswire 1
PR Newswire Canada 1
BNN Bloomberg 1

Event Lens

What the news is about

Classified themes
Market update 12
Earnings 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-14 of 14